B: 21-24 Flashcards
Dyslipidemia drugs
Atorvastatin
Rosuvastatin
Simvastatin
Ezetimib
Fenofibrate
Colesevelam
Evolocumab, Alirocumab (PCSK9 Inhibitor= inhibits degredation of LDL-R )
Statins MOA
HMG-CoA reductase inhibitors which is the rate limiting step of endogenous cholesterol synthesis
Statins actions
Liver cholesterol ↓
LDL-R expression ↑ (liver compensation to clear LDL, vLDL remnants from blood)
HDL ↑ 5-15%
Plasma LDL ↓ (20-50% reduction)
VLDL synthesis by liver ↓
Plasma TG ↓
Atorvastatin
Rosuvastatin
Simvastatin
Difference
Atorvastatin: Active as given
Rosuvastatin: Active as given
Simvastatin: Prodrug
Atorvastatin
Rosuvastatin
Simvastatin
Metabolism
CYP450
Atorvastatin
Rosuvastatin
Simvastatin
Indications
Atherosclerotic vascular disease
Acute coronary syndrome
Reduced risk of cardiovascular disease
Reduced mortality in ischemi heart dieseas
Statins side effects
Hepatotoxicity
Myalgia
Rhabdonyolysis
increase creat kinase in 10%
allergy “statin intolerance”
Statins contraindications
Teratogenic
Liver diseas caution
food which inhibit CYP450 eg grapefruit increase hepatotoxicity risk and myopathy.
Colesevelam MOA
resin
Bile acid binding resin are
Large non absorbable polymers that bind bile acid and prevent their absorption in intestine –> increase BA in intestiine > GI side effect
this divert hepatic cholesterol to the synthesis of new bile >> decreasing cholesterol in tightly regulated pool
Bile acid sequestrans drug
Colesevelam
colestipol
cholestyramine
Colesevelam how to give and when?
Oral
With meals
Dont give togather with other drugs (warfarin, thiazide, digoxin, aspirin, statin) and vitamins (K, folate) (wait btw. 4 h)
Colesevelam indications
Primary hypercholesterolemia type IIA (LDL↑)
With Statins
pruritis
Colesevelam side effects
VLDL ↑
TG ↑
- GI: bloat, constipation, diarrhea , Vit. ADEK malabsorption
- Hyperglycemia
- Gall stones
Sterol absorption inhibitors
Ezetimibe
Ezetimibe MOA
decrease intestinal absorption by
Block NPC1L1 in intestine
Reduce cholesterol absorption
Liver cholesterol ↓
LDL-R expression ↑
Plams LDL ↓ (20% reduction)
5% increase HDL
PCSK-9 inhibitors
Evolocumab, Alirocumab (PCSK9 Inhibitor= inhibits degredation of LDL-R )
Humanized monoclonal antibody against enzyme PCSK-9, which normally transport LDL-R to lysosomal degradation
- decreases LDL-R recycling > increase in LDL-R > Decreased LDL
se: Local rxn at site of injection, URT (flu-like symptoms)
Alirocumab, Evolocumab
indications
PCSK-9 inhibitors
- familial hypercholestermeia
- resistant hypercholesteremia
- statin intolerance
Carbonic Anhydrase inhibitors
Acetazolamide
Brinzolamide
Dorzolamid
Methazolamid
Acetazolamide indicaitons
- Diuretic use if edema+ metabolic alkalosis
- Glaucoma (topical brinzolamid, dorzolamid)- decreases secretion of H2CO3 by ciliary epi into aquous humor > decreases IOP
- Mountain sickness: decreases H2CO3 secretion into CSF pro by choroid plexus >> acidosis of CSF> Hyperventilation which protect against high alititude sickness
Innr ear disorder Urinary alkalosis (alkalinization of urine --\> ppt Ca salt --\> renal stones
Acetazolamide side effects
Metabolic acidosis Renal stones (due to urine alkalinization)
Rapid tolerance ( 1 week application only)
Renal K+ wasting
paraesthesia
Hyperammonemia in cirhosis ( due to urine alkalinization prevents NH3 > NH4+ > hepatic encephalopathy)
self-limiting diuresis in 2-3 days
Loop diuretics MOA and names
Furosemide
Torsemide
Ethacrynic acid
Inhibition of Na/K/2Cl in the thick ascending limb
Inhibition of Na/K/2Cl in the thick ascending limb will cause
Loss of NaCl
Loss of luminal positive potential (Mg,Ca reab.↓)
K and H wasting
Hypokalemic metabolic alkalosis
XOX-2 ↑ → GFR ↑
Furosemide drug interactions
NSAID’s (Decreases efficacy )
Aminoglycosides (ototoxicity)
Lithium
Digoxin
How are they different?
furosemide
ethacrynic acid
Furosemide is a Sulfa drug
Ethacrynic acid is not a Sulfa drug
BOTH are loop diuretics